Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01923168
Title Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

Her2-receptor negative breast cancer

Therapies

Buparlisib + Letrozole

Letrozole

Alpelisib + Letrozole

Age Groups: adult
Covered Countries USA | ITA | ESP | DEU | CAN | BEL | AUT

Facility Status City State Zip Country Details
University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI Birmingham Alabama 35294-0006 United States Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Los Angeles Hematology/Oncology Medical Group Onc Dept. Los Angeles California 90017 United States Details
University of California at Los Angeles UCLA SC Los Angeles California 90095 United States Details
University of California San Francisco BYL719A2201 - SC San Francisco California 94115 United States Details
Emory University School of Medicine/Winship Cancer Institute SC Atlanta Georgia 30322 United States Details
Mercy Medical Center Medical Oncology & Hematology Baltimore Maryland 21202 United States Details
Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Johns Hopkins Med. BYL719A2201 Baltimore Maryland 21231 United States Details
Dana Farber Cancer Institute BYL719A2201 Boston Massachusetts 02215 United States Details
Mayo Clinic - Rochester BYL719A2201 - SC Rochester Minnesota 55905 United States Details
Cancer Institute of New Jersey New Brunswick New Jersey 08901 United States Details
Duke University Medical Center Duke University Medical Center Durham North Carolina 27710 United States Details
Northwest Cancer Specialists Vancouver Loc Portland Oregon 97210 United States Details
Vanderbilt Ingram Cancer Center Vanderbilt Health 100 Oaks Nashville Tennessee 37203 United States Details
Texas Oncology, P.A. Bedford Texas 76022 United States Details
Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp Dallas Texas 75231 United States Details
Texas Oncology Texas Oncology - Sammons Dallas Texas 75246 United States Details
Texas Oncology Houston Memorial City SC Houston Texas 77024 United States Details
Cancer Care Centers of South Texas HOAST CCC of So. TX- San Antonio(2) San Antonio Texas 78229 United States Details
Cancer Therapy & Research Center UT Health Science Center InstituteForDrugDevelopment(5) San Antonio Texas 78229 United States Details
Virginia Oncology Associates SC Norfolk Virginia 23502 United States Details
Seattle Cancer Care Alliance SC-3 Seattle Washington 98105 United States Details
Northwest Medical Specialties Dept.ofNW Med. Specialties Tacoma Washington 98405 United States Details
Novartis Investigative Site Kingswood New South Wales 2747 Australia Details
Novartis Investigative Site Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Dornbirn Vorarlberg 6830 Austria Details
Novartis Investigative Site Leoben A-8700 Austria Details
Novartis Investigative Site Rankweil A-6830 Austria Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Vienna A-1090 Austria Details
Novartis Investigative Site Villach 9500 Austria Details
Novartis Investigative Site Wien A-1090 Austria Details
Novartis Investigative Site Edegem Antwerpen 2650 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Sint Niklaas 9100 Belgium Details
Novartis Investigative Site Goiania GO 74605-070 Brazil Details
Novartis Investigative Site Porto Alegre Rio Grande Do Sul 90610-000 Brazil Details
Novartis Investigative Site Ribeirao Preto SP 14048-900 Brazil Details
Novartis Investigative Site Sao Paulo SP 01317-002 Brazil Details
Novartis Investigative Site Sao Paulo SP 03102-002 Brazil Details
Novartis Investigative Site Shumen 9700 Bulgaria Details
Novartis Investigative Site Sofia 1303 Bulgaria Details
Novartis Investigative Site Varna 9010 Bulgaria Details
Novartis Investigative Site Vancouver British Columbia V5Z 4E6 Canada Details
Novartis Investigative Site Montreal Quebec H2W 1T8 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Quebec G1S 4L8 Canada Details
Novartis Investigative Site Medellin Antioquia Colombia Details
Novartis Investigative Site Bogota Colombia Details
Novartis Investigative Site Olomouc CZE 775 20 Czechia Details
Novartis Investigative Site Praha 12808 Czechia Details
Novartis Investigative Site Berlin 13125 Germany Details
Novartis Investigative Site Erlangen 91054 Germany Details
Novartis Investigative Site Essen 45136 Germany Details
Novartis Investigative Site Kiel 24105 Germany Details
Novartis Investigative Site Koeln 51067 Germany Details
Novartis Investigative Site Hong Kong SAR Hong Kong Details
Novartis Investigative Site Haifa 3525408 Israel Details
Novartis Investigative Site Ramat Gan 5265601 Israel Details
Novartis Investigative Site Tel Aviv 64239 Israel Details
Novartis Investigative Site Brescia BS 25127 Italy Details
Novartis Investigative Site Cremona CR 26100 Italy Details
Novartis Investigative Site Macerata MC 62100 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Nagoya-city Aichi 467-8602 Japan Details
Novartis Investigative Site Hiroshima-city Hiroshima 730-8518 Japan Details
Novartis Investigative Site Osaka-city Osaka 540-0006 Japan Details
Novartis Investigative Site Bunkyo-ku Tokyo 113-8677 Japan Details
Novartis Investigative Site Koto-ku Tokyo 135 8550 Japan Details
Novartis Investigative Site Niigata 951-8566 Japan Details
Novartis Investigative Site Ashrafieh 166830 Lebanon Details
Novartis Investigative Site Beirut Lebanon Details
Novartis Investigative Site Saida 652 Lebanon Details
Novartis Investigative Site Delft 2625 AD Netherlands Details
Novartis Investigative Site Den Haag 2545 CH Netherlands Details
Novartis Investigative Site Leiden 2300 RC Netherlands Details
Novartis Investigative Site Tilburg 5022 GC Netherlands Details
Novartis Investigative Site Sevilla Andalucia 41017 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site La Coruna Galicia 15006 Spain Details
Novartis Investigative Site San Sebastián Pais Vasco 20014 Spain Details
Novartis Investigative Site Madrid 28007 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field